1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intervertebral Implants Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Intervertebral Implants Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Technological Advancements
    5.2. Disease Prevalence & Incidence Rate globally
    5.3. Pricing Analysis
    5.4. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
    5.5. COVID-19 Pandemic Impact on Industry
6. Global Intervertebral Implants Market Analysis and Forecast, By Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast By Type, 2017–2031
        6.3.1. Cervical
        6.3.2. Lumbar
        6.3.3. Others
    6.4. Market Attractiveness By Type
7. Global Intervertebral Implants Market Analysis and Forecast, By Material
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast By Material, 2017–2031
        7.3.1. Titanium
        7.3.2. Polyetheretherketone (PEEK)
        7.3.3. Others
    7.4. Market Attractiveness By Material
8. Global Intervertebral Implants Market Analysis and Forecast, By End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast By End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Ambulatory Surgical Centers
        8.3.3. Clinics and Orthopedic Centers
    8.4. Market Attractiveness By End-user
9. Global Intervertebral Implants Market Analysis and Forecast, By Region
    9.1. Key Findings
    9.2. Market Value Forecast By Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness By Country/Region
10. North America Intervertebral Implants Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast By Type, 2017–2031
        10.2.1. Cervical
        10.2.2. Lumbar
        10.2.3. Others
    10.3. Market Value Forecast By Material, 2017–2031
        10.3.1. Titanium
        10.3.2. Polyetheretherketone (PEEK)
        10.3.3. Others
    10.4. Market Value Forecast By End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Ambulatory Surgical Centers
        10.4.3. Clinics and Orthopedic Centers
    10.5. Market Value Forecast By Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Type
        10.6.2. By Material
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Intervertebral Implants Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Type, 2017–2031
        11.2.1. Cervical
        11.2.2. Lumbar
        11.2.3. Others
    11.3. Market Value Forecast By Material, 2017–2031
        11.3.1. Titanium
        11.3.2. Polyetheretherketone (PEEK)
        11.3.3. Others
    11.4. Market Value Forecast By End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Ambulatory Surgical Centers
        11.4.3. Clinics and Orthopedic Centers
    11.5. Market Value Forecast By Country/Sub-Region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Type
        11.6.2. By Material
        11.6.3. By End-user
        11.6.4. By Country/Sub-Region
12. Asia Pacific Intervertebral Implants Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Type, 2017–2031
        12.2.1. Cervical
        12.2.2. Lumbar
        12.2.3. Others
    12.3. Market Value Forecast By Material, 2017–2031
        12.3.1. Titanium
        12.3.2. Polyetheretherketone (PEEK)
        12.3.3. Others
    12.4. Market Value Forecast By End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Ambulatory Surgical Centers
        12.4.3. Clinics and Orthopedic Centers
    12.5. Market Value Forecast By Country/Sub-Region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Type
        12.6.2. By Material
        12.6.3. By End-user
        12.6.4. By Country/Sub-Region
13. Latin America Intervertebral Implants Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Type, 2017–2031
        13.2.1. Cervical
        13.2.2. Lumbar
        13.2.3. Others
    13.3. Market Value Forecast By Material, 2017–2031
        13.3.1. Titanium
        13.3.2. Polyetheretherketone (PEEK)
        13.3.3. Others
    13.4. Market Value Forecast By End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Ambulatory Surgical Centers
        13.4.3. Clinics and Orthopedic Centers
    13.5. Market Value Forecast By Country/Sub-Region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Type
        13.6.2. By Material
        13.6.3. By End-user
        13.6.4. By Country/Sub-Region
14. Middle East & Africa Intervertebral Implants Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Type, 2017–2031
        14.2.1. Cervical
        14.2.2. Lumbar
        14.2.3. Others
    14.3. Market Value Forecast By Material, 2017–2031
        14.3.1. Titanium
        14.3.2. Polyetheretherketone (PEEK)
        14.3.3. Others
    14.4. Market Value Forecast By End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Ambulatory Surgical Centers
        14.4.3. Clinics and Orthopedic Centers
    14.5. Market Value Forecast By Country/Sub-Region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Type
        14.6.2. By Material
        14.6.3. By End-user
        14.6.4. By Country/Sub-Region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    15.2. Company Profiles
        15.2.1. Alphatec Spine, Inc.
            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.1.2. Product Portfolio
            15.2.1.3. Financial Overview
            15.2.1.4. SWOT Analysis
            15.2.1.5. Strategic Overview
        15.2.2. B. Braun Melsungen AG
            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.2.2. Product Portfolio
            15.2.2.3. Financial Overview
            15.2.2.4. SWOT Analysis
            15.2.2.5. Strategic Overview
        15.2.3. Companion Spine LLC
            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.3.2. Product Portfolio
            15.2.3.3. Financial Overview
            15.2.3.4. SWOT Analysis
            15.2.3.5. Strategic Overview
        15.2.4. DePuy Synthes (Johnson & Johnson)
            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.4.2. Product Portfolio
            15.2.4.3. Financial Overview
            15.2.4.4. SWOT Analysis
            15.2.4.5. Strategic Overview
        15.2.5. Globus Medical, Inc.
            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.5.2. Product Portfolio
            15.2.5.3. Financial Overview
            15.2.5.4. SWOT Analysis
            15.2.5.5. Strategic Overview
        15.2.6. LASAK s.r.o.
            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.6.2. Product Portfolio
            15.2.6.3. Financial Overview
            15.2.6.4. SWOT Analysis
            15.2.6.5. Strategic Overview
        15.2.7. NuVasive, Inc.
            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.7.2. Product Portfolio
            15.2.7.3. Financial Overview
            15.2.7.4. SWOT Analysis
            15.2.7.5. Strategic Overview
        15.2.8. Spineology Inc.
            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.8.2. Product Portfolio
            15.2.8.3. Financial Overview
            15.2.8.4. SWOT Analysis
            15.2.8.5. Strategic Overview
        15.2.9. Stryker Corporation
            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.9.2. Product Portfolio
            15.2.9.3. Financial Overview
            15.2.9.4. SWOT Analysis
            15.2.9.5. Strategic Overview
        15.2.10. Xtant Medical
            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.10.2. Product Portfolio
            15.2.10.3. Financial Overview
            15.2.10.4. SWOT Analysis
            15.2.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			